【市場調査レポート】長時間作用型スルホンアミドのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Long Acting Sulfonamide Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。長時間作用型スルホンアミドのグローバル市場インサイト・予測（～2028年） / Global Long Acting Sulfonamide Market Insights, Forecast to 2028 / QY2207E10399資料のイメージです。

• レポートコード：QY2207E10399
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、87ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の長時間作用型スルホンアミドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に長時間作用型スルホンアミドの世界市場のxxx％を占める「腸管吸収」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「全身感染症」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の長時間作用型スルホンアミドの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの長時間作用型スルホンアミド市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの長時間作用型スルホンアミド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

長時間作用型スルホンアミドのグローバル主要メーカーには、Pfizer、Sanofi、Roche、Mylan、Teva、Bayer、Abbott、GlaxoSmithKline、Boehringer Ingelheimなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

長時間作用型スルホンアミド市場は、種類と用途によって区分されます。世界の長時間作用型スルホンアミド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
腸管吸収、腸管難吸収、外用

【用途別セグメント】
全身感染症、腸感染症、火傷感染症、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 長時間作用型スルホンアミド製品概要
- 種類別市場（腸管吸収、腸管難吸収、外用）
- 用途別市場（全身感染症、腸感染症、火傷感染症、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の長時間作用型スルホンアミド販売量予測2017-2028
- 世界の長時間作用型スルホンアミド売上予測2017-2028
- 長時間作用型スルホンアミドの地域別販売量
- 長時間作用型スルホンアミドの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別長時間作用型スルホンアミド販売量
- 主要メーカー別長時間作用型スルホンアミド売上
- 主要メーカー別長時間作用型スルホンアミド価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（腸管吸収、腸管難吸収、外用）
- 長時間作用型スルホンアミドの種類別販売量
- 長時間作用型スルホンアミドの種類別売上
- 長時間作用型スルホンアミドの種類別価格
・用途別市場規模（全身感染症、腸感染症、火傷感染症、その他）
- 長時間作用型スルホンアミドの用途別販売量
- 長時間作用型スルホンアミドの用途別売上
- 長時間作用型スルホンアミドの用途別価格
・北米市場
- 北米の長時間作用型スルホンアミド市場規模（種類別、用途別）
- 主要国別の長時間作用型スルホンアミド市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの長時間作用型スルホンアミド市場規模（種類別、用途別）
- 主要国別の長時間作用型スルホンアミド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の長時間作用型スルホンアミド市場規模（種類別、用途別）
- 主要国別の長時間作用型スルホンアミド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の長時間作用型スルホンアミド市場規模（種類別、用途別）
- 主要国別の長時間作用型スルホンアミド市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの長時間作用型スルホンアミド市場規模（種類別、用途別）
- 主要国別の長時間作用型スルホンアミド市場規模（トルコ、サウジアラビア）
・企業情報
Pfizer、Sanofi、Roche、Mylan、Teva、Bayer、Abbott、GlaxoSmithKline、Boehringer Ingelheim
・産業チェーン及び販売チャネル分析
- 長時間作用型スルホンアミドの産業チェーン分析
- 長時間作用型スルホンアミドの原材料
- 長時間作用型スルホンアミドの生産プロセス
- 長時間作用型スルホンアミドの販売及びマーケティング
- 長時間作用型スルホンアミドの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 長時間作用型スルホンアミドの産業動向
- 長時間作用型スルホンアミドのマーケットドライバー
- 長時間作用型スルホンアミドの課題
- 長時間作用型スルホンアミドの阻害要因
・主な調査結果

Market Analysis and Insights: Global Long Acting Sulfonamide Market
Due to the COVID-19 pandemic, the global Long Acting Sulfonamide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Intestinal Absorption accounting for % of the Long Acting Sulfonamide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Systemic Infection segment is altered to an % CAGR throughout this forecast period.
China Long Acting Sulfonamide market size is valued at US$ million in 2021, while the US and Europe Long Acting Sulfonamide are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Long Acting Sulfonamide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Long Acting Sulfonamide include Pfizer, Sanofi, Roche, Mylan, Teva, Bayer, Abbott, GlaxoSmithKline and Boehringer Ingelheim. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Long Acting Sulfonamide Scope and Segment
Long Acting Sulfonamide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Long Acting Sulfonamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Intestinal Absorption
Intestinal Tract Difficult to Absorb
External Use
Segment by Application
Systemic Infection
Intestinal Infection
Burn Infection
Other Infections
By Company
Pfizer
Sanofi
Roche
Mylan
Teva
Bayer
Abbott
GlaxoSmithKline
Boehringer Ingelheim
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Long Acting Sulfonamide Product Introduction
1.2 Market by Type
1.2.1 Global Long Acting Sulfonamide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Intestinal Absorption
1.2.3 Intestinal Tract Difficult to Absorb
1.2.4 External Use
1.3 Market by Application
1.3.1 Global Long Acting Sulfonamide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Systemic Infection
1.3.3 Intestinal Infection
1.3.4 Burn Infection
1.3.5 Other Infections
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Long Acting Sulfonamide Sales Estimates and Forecasts 2017-2028
2.2 Global Long Acting Sulfonamide Revenue Estimates and Forecasts 2017-2028
2.3 Global Long Acting Sulfonamide Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Long Acting Sulfonamide Sales by Region
2.4.1 Global Long Acting Sulfonamide Sales by Region (2017-2022)
2.4.2 Global Sales Long Acting Sulfonamide by Region (2023-2028)
2.5 Global Long Acting Sulfonamide Revenue by Region
2.5.1 Global Long Acting Sulfonamide Revenue by Region (2017-2022)
2.5.2 Global Long Acting Sulfonamide Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Long Acting Sulfonamide Sales by Manufacturers
3.1.1 Global Top Long Acting Sulfonamide Manufacturers by Sales (2017-2022)
3.1.2 Global Long Acting Sulfonamide Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Long Acting Sulfonamide in 2021
3.2 Global Long Acting Sulfonamide Revenue by Manufacturers
3.2.1 Global Long Acting Sulfonamide Revenue by Manufacturers (2017-2022)
3.2.2 Global Long Acting Sulfonamide Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Long Acting Sulfonamide Revenue in 2021
3.3 Global Long Acting Sulfonamide Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Long Acting Sulfonamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Long Acting Sulfonamide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Long Acting Sulfonamide Sales by Type
4.1.1 Global Long Acting Sulfonamide Historical Sales by Type (2017-2022)
4.1.2 Global Long Acting Sulfonamide Forecasted Sales by Type (2023-2028)
4.1.3 Global Long Acting Sulfonamide Sales Market Share by Type (2017-2028)
4.2 Global Long Acting Sulfonamide Revenue by Type
4.2.1 Global Long Acting Sulfonamide Historical Revenue by Type (2017-2022)
4.2.2 Global Long Acting Sulfonamide Forecasted Revenue by Type (2023-2028)
4.2.3 Global Long Acting Sulfonamide Revenue Market Share by Type (2017-2028)
4.3 Global Long Acting Sulfonamide Price by Type
4.3.1 Global Long Acting Sulfonamide Price by Type (2017-2022)
4.3.2 Global Long Acting Sulfonamide Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Long Acting Sulfonamide Sales by Application
5.1.1 Global Long Acting Sulfonamide Historical Sales by Application (2017-2022)
5.1.2 Global Long Acting Sulfonamide Forecasted Sales by Application (2023-2028)
5.1.3 Global Long Acting Sulfonamide Sales Market Share by Application (2017-2028)
5.2 Global Long Acting Sulfonamide Revenue by Application
5.2.1 Global Long Acting Sulfonamide Historical Revenue by Application (2017-2022)
5.2.2 Global Long Acting Sulfonamide Forecasted Revenue by Application (2023-2028)
5.2.3 Global Long Acting Sulfonamide Revenue Market Share by Application (2017-2028)
5.3 Global Long Acting Sulfonamide Price by Application
5.3.1 Global Long Acting Sulfonamide Price by Application (2017-2022)
5.3.2 Global Long Acting Sulfonamide Price Forecast by Application (2023-2028)
6 North America
6.1 North America Long Acting Sulfonamide Market Size by Type
6.1.1 North America Long Acting Sulfonamide Sales by Type (2017-2028)
6.1.2 North America Long Acting Sulfonamide Revenue by Type (2017-2028)
6.2 North America Long Acting Sulfonamide Market Size by Application
6.2.1 North America Long Acting Sulfonamide Sales by Application (2017-2028)
6.2.2 North America Long Acting Sulfonamide Revenue by Application (2017-2028)
6.3 North America Long Acting Sulfonamide Market Size by Country
6.3.1 North America Long Acting Sulfonamide Sales by Country (2017-2028)
6.3.2 North America Long Acting Sulfonamide Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Long Acting Sulfonamide Market Size by Type
7.1.1 Europe Long Acting Sulfonamide Sales by Type (2017-2028)
7.1.2 Europe Long Acting Sulfonamide Revenue by Type (2017-2028)
7.2 Europe Long Acting Sulfonamide Market Size by Application
7.2.1 Europe Long Acting Sulfonamide Sales by Application (2017-2028)
7.2.2 Europe Long Acting Sulfonamide Revenue by Application (2017-2028)
7.3 Europe Long Acting Sulfonamide Market Size by Country
7.3.1 Europe Long Acting Sulfonamide Sales by Country (2017-2028)
7.3.2 Europe Long Acting Sulfonamide Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Long Acting Sulfonamide Market Size by Type
8.1.1 Asia Pacific Long Acting Sulfonamide Sales by Type (2017-2028)
8.1.2 Asia Pacific Long Acting Sulfonamide Revenue by Type (2017-2028)
8.2 Asia Pacific Long Acting Sulfonamide Market Size by Application
8.2.1 Asia Pacific Long Acting Sulfonamide Sales by Application (2017-2028)
8.2.2 Asia Pacific Long Acting Sulfonamide Revenue by Application (2017-2028)
8.3 Asia Pacific Long Acting Sulfonamide Market Size by Region
8.3.1 Asia Pacific Long Acting Sulfonamide Sales by Region (2017-2028)
8.3.2 Asia Pacific Long Acting Sulfonamide Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Long Acting Sulfonamide Market Size by Type
9.1.1 Latin America Long Acting Sulfonamide Sales by Type (2017-2028)
9.1.2 Latin America Long Acting Sulfonamide Revenue by Type (2017-2028)
9.2 Latin America Long Acting Sulfonamide Market Size by Application
9.2.1 Latin America Long Acting Sulfonamide Sales by Application (2017-2028)
9.2.2 Latin America Long Acting Sulfonamide Revenue by Application (2017-2028)
9.3 Latin America Long Acting Sulfonamide Market Size by Country
9.3.1 Latin America Long Acting Sulfonamide Sales by Country (2017-2028)
9.3.2 Latin America Long Acting Sulfonamide Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Long Acting Sulfonamide Market Size by Type
10.1.1 Middle East and Africa Long Acting Sulfonamide Sales by Type (2017-2028)
10.1.2 Middle East and Africa Long Acting Sulfonamide Revenue by Type (2017-2028)
10.2 Middle East and Africa Long Acting Sulfonamide Market Size by Application
10.2.1 Middle East and Africa Long Acting Sulfonamide Sales by Application (2017-2028)
10.2.2 Middle East and Africa Long Acting Sulfonamide Revenue by Application (2017-2028)
10.3 Middle East and Africa Long Acting Sulfonamide Market Size by Country
10.3.1 Middle East and Africa Long Acting Sulfonamide Sales by Country (2017-2028)
10.3.2 Middle East and Africa Long Acting Sulfonamide Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Long Acting Sulfonamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Long Acting Sulfonamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Overview
11.3.3 Roche Long Acting Sulfonamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Roche Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Long Acting Sulfonamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Overview
11.5.3 Teva Long Acting Sulfonamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Teva Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Recent Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Overview
11.6.3 Bayer Long Acting Sulfonamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bayer Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer Recent Developments
11.7 Abbott
11.7.1 Abbott Corporation Information
11.7.2 Abbott Overview
11.7.3 Abbott Long Acting Sulfonamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Abbott Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Overview
11.8.3 GlaxoSmithKline Long Acting Sulfonamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GlaxoSmithKline Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GlaxoSmithKline Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Overview
11.9.3 Boehringer Ingelheim Long Acting Sulfonamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Boehringer Ingelheim Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Boehringer Ingelheim Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Long Acting Sulfonamide Industry Chain Analysis
12.2 Long Acting Sulfonamide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Long Acting Sulfonamide Production Mode & Process
12.4 Long Acting Sulfonamide Sales and Marketing
12.4.1 Long Acting Sulfonamide Sales Channels
12.4.2 Long Acting Sulfonamide Distributors
12.5 Long Acting Sulfonamide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Long Acting Sulfonamide Industry Trends
13.2 Long Acting Sulfonamide Market Drivers
13.3 Long Acting Sulfonamide Market Challenges
13.4 Long Acting Sulfonamide Market Restraints
14 Key Findings in The Global Long Acting Sulfonamide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Long Acting Sulfonamide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Intestinal Absorption
Table 3. Major Manufacturers of Intestinal Tract Difficult to Absorb
Table 4. Major Manufacturers of External Use
Table 5. Global Long Acting Sulfonamide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Long Acting Sulfonamide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Long Acting Sulfonamide Sales by Region (2017-2022) & (K Units)
Table 8. Global Long Acting Sulfonamide Sales Market Share by Region (2017-2022)
Table 9. Global Long Acting Sulfonamide Sales by Region (2023-2028) & (K Units)
Table 10. Global Long Acting Sulfonamide Sales Market Share by Region (2023-2028)
Table 11. Global Long Acting Sulfonamide Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Long Acting Sulfonamide Revenue Market Share by Region (2017-2022)
Table 13. Global Long Acting Sulfonamide Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Long Acting Sulfonamide Revenue Market Share by Region (2023-2028)
Table 15. Global Long Acting Sulfonamide Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Long Acting Sulfonamide Sales Share by Manufacturers (2017-2022)
Table 17. Global Long Acting Sulfonamide Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Long Acting Sulfonamide Revenue Share by Manufacturers (2017-2022)
Table 19. Long Acting Sulfonamide Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Long Acting Sulfonamide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Long Acting Sulfonamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Sulfonamide as of 2021)
Table 22. Long Acting Sulfonamide Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Long Acting Sulfonamide Product Offered
Table 24. Date of Manufacturers Enter into Long Acting Sulfonamide Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Long Acting Sulfonamide Sales by Type (2017-2022) & (K Units)
Table 27. Global Long Acting Sulfonamide Sales by Type (2023-2028) & (K Units)
Table 28. Global Long Acting Sulfonamide Sales Share by Type (2017-2022)
Table 29. Global Long Acting Sulfonamide Sales Share by Type (2023-2028)
Table 30. Global Long Acting Sulfonamide Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Long Acting Sulfonamide Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Long Acting Sulfonamide Revenue Share by Type (2017-2022)
Table 33. Global Long Acting Sulfonamide Revenue Share by Type (2023-2028)
Table 34. Long Acting Sulfonamide Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Long Acting Sulfonamide Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Long Acting Sulfonamide Sales by Application (2017-2022) & (K Units)
Table 37. Global Long Acting Sulfonamide Sales by Application (2023-2028) & (K Units)
Table 38. Global Long Acting Sulfonamide Sales Share by Application (2017-2022)
Table 39. Global Long Acting Sulfonamide Sales Share by Application (2023-2028)
Table 40. Global Long Acting Sulfonamide Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Long Acting Sulfonamide Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Long Acting Sulfonamide Revenue Share by Application (2017-2022)
Table 43. Global Long Acting Sulfonamide Revenue Share by Application (2023-2028)
Table 44. Long Acting Sulfonamide Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Long Acting Sulfonamide Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Long Acting Sulfonamide Sales by Type (2017-2022) & (K Units)
Table 47. North America Long Acting Sulfonamide Sales by Type (2023-2028) & (K Units)
Table 48. North America Long Acting Sulfonamide Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Long Acting Sulfonamide Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Long Acting Sulfonamide Sales by Application (2017-2022) & (K Units)
Table 51. North America Long Acting Sulfonamide Sales by Application (2023-2028) & (K Units)
Table 52. North America Long Acting Sulfonamide Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Long Acting Sulfonamide Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Long Acting Sulfonamide Sales by Country (2017-2022) & (K Units)
Table 55. North America Long Acting Sulfonamide Sales by Country (2023-2028) & (K Units)
Table 56. North America Long Acting Sulfonamide Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Long Acting Sulfonamide Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Long Acting Sulfonamide Sales by Type (2017-2022) & (K Units)
Table 59. Europe Long Acting Sulfonamide Sales by Type (2023-2028) & (K Units)
Table 60. Europe Long Acting Sulfonamide Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Long Acting Sulfonamide Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Long Acting Sulfonamide Sales by Application (2017-2022) & (K Units)
Table 63. Europe Long Acting Sulfonamide Sales by Application (2023-2028) & (K Units)
Table 64. Europe Long Acting Sulfonamide Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Long Acting Sulfonamide Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Long Acting Sulfonamide Sales by Country (2017-2022) & (K Units)
Table 67. Europe Long Acting Sulfonamide Sales by Country (2023-2028) & (K Units)
Table 68. Europe Long Acting Sulfonamide Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Long Acting Sulfonamide Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Long Acting Sulfonamide Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Long Acting Sulfonamide Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Long Acting Sulfonamide Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Long Acting Sulfonamide Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Long Acting Sulfonamide Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Long Acting Sulfonamide Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Long Acting Sulfonamide Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Long Acting Sulfonamide Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Long Acting Sulfonamide Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Long Acting Sulfonamide Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Long Acting Sulfonamide Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Long Acting Sulfonamide Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Long Acting Sulfonamide Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Long Acting Sulfonamide Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Long Acting Sulfonamide Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Long Acting Sulfonamide Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Long Acting Sulfonamide Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Long Acting Sulfonamide Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Long Acting Sulfonamide Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Long Acting Sulfonamide Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Long Acting Sulfonamide Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Long Acting Sulfonamide Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Long Acting Sulfonamide Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Long Acting Sulfonamide Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Long Acting Sulfonamide Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Long Acting Sulfonamide Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Long Acting Sulfonamide Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Long Acting Sulfonamide Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Long Acting Sulfonamide Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Long Acting Sulfonamide Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Long Acting Sulfonamide Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Long Acting Sulfonamide Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Long Acting Sulfonamide Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Long Acting Sulfonamide Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Long Acting Sulfonamide Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Long Acting Sulfonamide Revenue by Country (2023-2028) & (US$ Million)
Table 106. Pfizer Corporation Information
Table 107. Pfizer Description and Major Businesses
Table 108. Pfizer Long Acting Sulfonamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Pfizer Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Pfizer Recent Developments
Table 111. Sanofi Corporation Information
Table 112. Sanofi Description and Major Businesses
Table 113. Sanofi Long Acting Sulfonamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Sanofi Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Sanofi Recent Developments
Table 116. Roche Corporation Information
Table 117. Roche Description and Major Businesses
Table 118. Roche Long Acting Sulfonamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Roche Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Roche Recent Developments
Table 121. Mylan Corporation Information
Table 122. Mylan Description and Major Businesses
Table 123. Mylan Long Acting Sulfonamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Mylan Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Mylan Recent Developments
Table 126. Teva Corporation Information
Table 127. Teva Description and Major Businesses
Table 128. Teva Long Acting Sulfonamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Teva Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Teva Recent Developments
Table 131. Bayer Corporation Information
Table 132. Bayer Description and Major Businesses
Table 133. Bayer Long Acting Sulfonamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Bayer Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Bayer Recent Developments
Table 136. Abbott Corporation Information
Table 137. Abbott Description and Major Businesses
Table 138. Abbott Long Acting Sulfonamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Abbott Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Abbott Recent Developments
Table 141. GlaxoSmithKline Corporation Information
Table 142. GlaxoSmithKline Description and Major Businesses
Table 143. GlaxoSmithKline Long Acting Sulfonamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. GlaxoSmithKline Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. GlaxoSmithKline Recent Developments
Table 146. Boehringer Ingelheim Corporation Information
Table 147. Boehringer Ingelheim Description and Major Businesses
Table 148. Boehringer Ingelheim Long Acting Sulfonamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Boehringer Ingelheim Long Acting Sulfonamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Boehringer Ingelheim Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Long Acting Sulfonamide Distributors List
Table 154. Long Acting Sulfonamide Customers List
Table 155. Long Acting Sulfonamide Market Trends
Table 156. Long Acting Sulfonamide Market Drivers
Table 157. Long Acting Sulfonamide Market Challenges
Table 158. Long Acting Sulfonamide Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Long Acting Sulfonamide Product Picture
Figure 3. Global Long Acting Sulfonamide Market Share by Type in 2021 & 2028
Figure 3. Intestinal Absorption Product Picture
Figure 4. Intestinal Tract Difficult to Absorb Product Picture
Figure 5. External Use Product Picture
Figure 6. Global Long Acting Sulfonamide Market Share by Application in 2021 & 2028
Figure 7. Systemic Infection
Figure 8. Intestinal Infection
Figure 9. Burn Infection
Figure 10. Other Infections
Figure 11. Long Acting Sulfonamide Report Years Considered
Figure 12. Global Long Acting Sulfonamide Sales 2017-2028 (K Units)
Figure 13. Global Long Acting Sulfonamide Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Long Acting Sulfonamide Revenue 2017-2028 (US$ Million)
Figure 15. Global Long Acting Sulfonamide Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Long Acting Sulfonamide Sales Market Share by Region (2017-2022)
Figure 17. Global Long Acting Sulfonamide Sales Market Share by Region (2023-2028)
Figure 18. North America Long Acting Sulfonamide Sales YoY (2017-2028) & (K Units)
Figure 19. North America Long Acting Sulfonamide Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Long Acting Sulfonamide Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Long Acting Sulfonamide Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Long Acting Sulfonamide Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Long Acting Sulfonamide Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Long Acting Sulfonamide Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Long Acting Sulfonamide Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Long Acting Sulfonamide Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Long Acting Sulfonamide Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Long Acting Sulfonamide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Long Acting Sulfonamide in the World: Market Share by Long Acting Sulfonamide Revenue in 2021
Figure 30. Global Long Acting Sulfonamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Long Acting Sulfonamide Sales Market Share by Type (2017-2028)
Figure 32. Global Long Acting Sulfonamide Revenue Market Share by Type (2017-2028)
Figure 33. Global Long Acting Sulfonamide Sales Market Share by Application (2017-2028)
Figure 34. Global Long Acting Sulfonamide Revenue Market Share by Application (2017-2028)
Figure 35. North America Long Acting Sulfonamide Sales Market Share by Type (2017-2028)
Figure 36. North America Long Acting Sulfonamide Revenue Market Share by Type (2017-2028)
Figure 37. North America Long Acting Sulfonamide Sales Market Share by Application (2017-2028)
Figure 38. North America Long Acting Sulfonamide Revenue Market Share by Application (2017-2028)
Figure 39. North America Long Acting Sulfonamide Sales Share by Country (2017-2028)
Figure 40. North America Long Acting Sulfonamide Revenue Share by Country (2017-2028)
Figure 41. United States Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Long Acting Sulfonamide Sales Market Share by Type (2017-2028)
Figure 44. Europe Long Acting Sulfonamide Revenue Market Share by Type (2017-2028)
Figure 45. Europe Long Acting Sulfonamide Sales Market Share by Application (2017-2028)
Figure 46. Europe Long Acting Sulfonamide Revenue Market Share by Application (2017-2028)
Figure 47. Europe Long Acting Sulfonamide Sales Share by Country (2017-2028)
Figure 48. Europe Long Acting Sulfonamide Revenue Share by Country (2017-2028)
Figure 49. Germany Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 50. France Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Long Acting Sulfonamide Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Long Acting Sulfonamide Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Long Acting Sulfonamide Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Long Acting Sulfonamide Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Long Acting Sulfonamide Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Long Acting Sulfonamide Revenue Share by Region (2017-2028)
Figure 60. China Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 63. India Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Long Acting Sulfonamide Sales Market Share by Type (2017-2028)
Figure 70. Latin America Long Acting Sulfonamide Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Long Acting Sulfonamide Sales Market Share by Application (2017-2028)
Figure 72. Latin America Long Acting Sulfonamide Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Long Acting Sulfonamide Sales Share by Country (2017-2028)
Figure 74. Latin America Long Acting Sulfonamide Revenue Share by Country (2017-2028)
Figure 75. Mexico Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Long Acting Sulfonamide Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Long Acting Sulfonamide Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Long Acting Sulfonamide Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Long Acting Sulfonamide Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Long Acting Sulfonamide Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Long Acting Sulfonamide Revenue Share by Country (2017-2028)
Figure 84. Turkey Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Long Acting Sulfonamide Revenue (2017-2028) & (US$ Million)
Figure 87. Long Acting Sulfonamide Value Chain
Figure 88. Long Acting Sulfonamide Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

以下、関連資料のご紹介

超長時間作用性ベータ刺激薬のグローバル市場インサイト・予測（～2028年）

Global Ultra Long Acting Beta Agonist Market Insights, Forecast to 2028
QY2207E10506 2022年7月 93Pages
新型コロナウイルス感染症のパンデミックにより、世界の超長時間作用性ベータ刺激薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に超長時間作...

長時間作用型可逆性避妊薬（LARC）のグローバル市場インサイト・予測（～2028年）

Global Long-acting Reversible Contraceptives (LARCs) Market Insights, Forecast to 2028
QY2207E09669 2022年7月 117Pages
新型コロナウイルス感染症のパンデミックにより、世界の長時間作用型可逆性避妊薬（LARC）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...

超短時間作用型バルビツール酸塩のグローバル市場インサイト・予測（～2028年）

Global Ultra Short Acting Barbiturates Market Insights, Forecast to 2028
QY2207E10509 2022年7月 105Pages
新型コロナウイルス感染症のパンデミックにより、世界の超短時間作用型バルビツール酸塩の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に超短時...

超短時間作用型ベータ遮断薬のグローバル市場インサイト・予測（～2028年）

Global Ultra Short Acting Beta Blocker Market Insights, Forecast to 2028
QY2207E10511 2022年7月 106Pages
新型コロナウイルス感染症のパンデミックにより、世界の超短時間作用型ベータ遮断薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に超短時間作...

ロングラムジャックのグローバル市場インサイト・予測（～2028年）

Global Long Ram Jack Market Insights, Forecast to 2028
QY2207E07009 2022年7月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界のロングラムジャックの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にロングラムジャック...

超長時間作用性ベータ刺激薬のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Ultra Long Acting Beta Agonist Market Due to the COVID-19 pandemic, the global Ultra Long Acting Beta Agonist market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast…
長時間作用型可逆性避妊薬（LARC）のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Long-acting Reversible Contraceptives (LARCs) Market Due to the COVID-19 pandemic, the global Long-acting Reversible Contraceptives (LARCs) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a…
院内感染検査のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Hospital Acquired Infection Testing Market The global Hospital Acquired Infection Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis…
尿路感染症（UTI）検査ストリップのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Urinary Tract Infection (UTI) Test Strips Market Due to the COVID-19 pandemic, the global Urinary Tract Infection (UTI) Test Strips market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of…
感染予防・制御装置のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Infection Prevention and Control Equipment Market The global Infection Prevention and Control Equipment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this…